The Recall Desk
ModerateFDA (Drugs)·D-428-2013·Announced 2013-05-29

Levoxyl Tablets Recalled for Low Potency at Expiry

King Legacy is recalling Levoxyl tablets because they were below specification for potency at the expiry stability point.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which is a reasonable probability of temporary or medically reversible adverse health consequences. The hazard is subpotency, which is a quality defect rather than a contamination or acute safety risk like choking or fire.

Plain-English summary

King Legacy, a wholly owned subsidiary of Pfizer, is recalling Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg. The affected products are packaged in 100-count bottles (NDC 60793-857-01) and 1000-count bottles (NDC 60793-857-10). The recall involves 77,272 bottles distributed nationwide and in Puerto Rico.

The recall was initiated because the products were below specification for potency at the expiry stability point. This means the medication may not contain the full amount of active ingredient required by the time it reaches its expiration date.

Patients using Levoxyl should consult their healthcare provider for guidance on alternative treatment options. The specific lots affected include 64190, 64331, 65642, and 66297 for 100-count bottles, and 64326, 64332, and 65771 for 1000-count bottles.

The recalled product

Product
LEVOXYL (LEVOTHYROXINE SODIUM)
Brand
LEVOXYL
Affected units
77,272

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (11)

  • Lot # a) 64190
  • Exp. 4/13
  • 64331
  • Exp. 6/13
  • 65642
  • Exp. 7/13
  • and 66297
  • Exp. 9/13
  • b) 64326
  • 64332
  • and 65771

UPCs (11)

  • 0360793856018
  • 0360793850016
  • 0360793852010
  • 0360793851013
  • 0360793857015
  • 0360793853017
  • 0360793854014
  • 0360793858012
  • 0360793855011
  • 0360793859019
  • 0360793860015

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically:

Part of a larger recall action

This product is one of 11 recalled by King Legacy, a wholly owned subsidiary of Pfizer under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 11 products in this recall →

Same manufacturer · King Legacy, a wholly owned subsidiary of Pfizer

See all →